Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'
- PMID: 37803995
- DOI: 10.1111/jvh.13892
Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'
Comment in
-
Response to "Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'".J Viral Hepat. 2024 Jun;31(6):357-359. doi: 10.1111/jvh.13904. Epub 2023 Dec 8. J Viral Hepat. 2024. PMID: 38069467 No abstract available.
Comment on
-
Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial.J Viral Hepat. 2024 Jan;31(1):51-52. doi: 10.1111/jvh.13879. Epub 2023 Aug 8. J Viral Hepat. 2024. PMID: 37551747 No abstract available.
References
REFERENCES
-
- Blach S, Bregenzer A, Bruggmann P, et al. Assessing the hepatitis C epidemiology in Switzerland: it’s not that trivial. J Viral Hepat. 2024;31:51-52.
-
- Bertisch B, Schaetti C, Schmid P, et al. Chronic hepatitis C virus infections in Switzerland in 2020: lower than expected and suggesting achievement of WHO elimination targets. J Viral Hepat. 2023;30:667-684. https://doi.org/10.1111/jvh.13842
-
- Bihl F, Bruggmann P, Castro Batänjer E, et al. HCV disease burden and population segments in Switzerland. Liver Int off J Int Assoc Study Liver. 2022;42(2):330-339.
-
- Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.
-
- Agosti-Gonzalez R, Falcato L, Grischott T, Senn O, Bruggmann P. Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study. Swiss Med Wkly. 2023;153:40085.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
